FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to experimental pharmacology and genetic technologies. Disclosed is a method for increasing physical endurance in experiment on dysferlin-deficient mice. Male dysferlin-deficient mice B6.A/J-Dysfprmd single introduction of a two-vector preparation based on adeno-associated virus of serotype 9 containing a vector pAAV-Dysf5'-DV, bearing 5'-sequence of dysferlin cDNA, muscle-specific promoter MHCK7, chimeric intron, left inverted terminal repeat (L-ITR) and right inverted terminal repeat (R-ITR); and vector pAAV-Dysf3'-DV, bearing 3'-sequence of dysferlin cDNA, L-ITR, PolyA SV40 and R-ITR.
EFFECT: method leads to increased physical endurance in experiment on dysferlin-deficient mice, which is confirmed by results of test "retention on wire" in 3 months after introduction of the preparation.
1 cl, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF MAINTAINING STATIC ENDURANCE IN DYSFERLIN-DEFICIENT MICE IN EXPERIMENT | 2023 |
|
RU2829651C1 |
METHOD FOR IMPROVING PHYSICAL PERFORMANCE USING ADENO-ASSOCIATED VIRAL VECTOR IN EXPERIMENT ON DYSFERLIN-DEFICIENT MICE | 2023 |
|
RU2828839C1 |
METHOD OF MYODYSTROPHY CORRECTION USING ADENO-ASSOCIATED VIRAL VECTOR IN EXPERIMENT | 2022 |
|
RU2821544C1 |
METHOD FOR CORRECTING MUSCULAR DYSTROPHY USING PLASMID DNA IN DYSFERLIN-DEFICIENT MICE | 2022 |
|
RU2805357C1 |
CODON-OPTIMISED CDNA CODING HUMAN DYSFERLIN, GENETICALLY ENGINEERED CONSTRUCT, RECOMBINANT ADENOVIRUS AND PHARMACEUTICAL COMPOSITION FOR TREATING DYSFERLINOPATHIES | 2012 |
|
RU2527073C2 |
ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE IV A | 2019 |
|
RU2794960C2 |
VECTORS AND SEQUENCES FOR TREATING DISEASES | 2011 |
|
RU2588667C2 |
USING VECTOR FOR REDUCING IMMUNE RESPONSE IN VIRAL DELIVERY OF AIPL1 | 2023 |
|
RU2818342C1 |
VECTORS BASED ON ADENO-ASSOCIATED VIRUSES FOR TREATING MUCOPOLYSACCHARIDOSES | 2016 |
|
RU2744593C2 |
SET OF RECOMBINANT GENETIC VECTORS CODING BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV-1, IMMUNOBIOLOGICAL PREPARATION FOR TREATMENT AND PREVENTION OF HIV INFECTION AND METHOD OF ITS APPLICATION | 2024 |
|
RU2833072C1 |
Authors
Dates
2025-01-28—Published
2023-12-26—Filed